T1	Pharmacological_substance 49 59	Nevirapine
N1000 	Reference T1 MeSH:D019829	Nevirapine
T2	Pharmacological_substance 204 229	antiretroviral medication
T3	Pharmacological_substance 230 240	Nevirapine
N1001 	Reference T3 MeSH:D019829	Nevirapine
T4	Pharmacological_substance 242 245	NVP
N1002 	Reference T4 MeSH:D019829	NVP
T5	Pharmacological_substance 260 263	NVP
N1003 	Reference T5 MeSH:D019829	NVP
T6	Pharmacological_substance 269 315	non-nucleoside reverse transcriptase inhibitor
T8	Disorder 341 385	Human Immunodeficiency Virus (HIV) infection
N1 	Reference T8 UMLS:C0019693	Human Immunodeficiency Virus (HIV) infection
T11	Pharmacological_substance 506 516	zidovudine
N1004 	Reference T11 MeSH:D015215	zidovudine
T12	Pharmacological_substance 518 528	lamivudine
N1005 	Reference T12 MeSH:D019259	lamivudine
T13	Pharmacological_substance 534 543	indinavir
N1006 	Reference T13 MeSH:D019469	indinavir
T14	Pharmacological_substance 626 635	indinavir
N1007 	Reference T14 MeSH:D019469	indinavir
T15	Disorder 637 648	renal colic
N2 	Reference T15 UMLS:C0152169	renal colic
T16	Disorder 653 658	fever
N3 	Reference T16 UMLS:C0015967	fever
T17	Pharmacological_substance 661 671	nelfinavir
N1008 	Reference T17 MeSH:D019888	nelfinavir
T18	Pharmacological_substance 694 703	efavirenz
N1009 	Reference T18 MeSH:C098320	efavirenz
T19	Disorder 705 711	nausea
N4 	Reference T19 UMLS:C0027497	nausea
T20	Disorder 716 737	temporary memory loss
N5 	Reference T20 UMLS:C0233796	temporary memory loss
T21	Pharmacological_substance 796 799	NVP
N1010 	Reference T21 MeSH:D019829	NVP
T22	Pharmacological_substance 801 811	zidovudine
N1011 	Reference T22 MeSH:D015215	zidovudine
T23	Pharmacological_substance 817 827	lamivudine
N1012 	Reference T23 MeSH:D019259	lamivudine
T24	Disorder 896 913	taste disturbance
N6 	Reference T24 UMLS:C0013378	taste disturbance
T25	Disorder 919 929	xerostomia
N7 	Reference T25 UMLS:C0043352	xerostomia
T26	Pharmacological_substance 1227 1230	NVP
N1013 	Reference T26 MeSH:D019829	NVP
T27	Pharmacological_substance 1344 1369	antiretroviral medication
T34	Subject 402 423	29-year-old black man
T35	Disorder 673 687	cutaneous rash
N8 	Reference T35 UMLS:C0015230	cutaneous rash
T28	Disorder 831 845	whitish plaque
T39	Subject 1808 1815	patient
T40	Disorder 425 428	HIV
N9 	Reference T40 UMLS:C3854222	HIV
T44	Disorder 1308 1336	reactions in the oral cavity
T7	Disorder 1424 1427	HIV
N10 	Reference T7 UMLS:C3854222	HIV
T42	Pharmacological_substance 456 492	highly active antiretroviral therapy
T48	Pharmacological_substance 494 499	HAART
T50	Pharmacological_substance 968 973	HAART
T43	Pharmacological_substance 1380 1385	HAART
T47	Pharmacological_substance 1598 1603	HAART
T52	Disorder 1804 1807	HIV
N11 	Reference T52 UMLS:C3854222	HIV
T37	Coreferring_mention 745 756	the patient
T41	Speculation_cue 1299 1307	possible
T36	Combination 813 816	and
T9	Combination 530 533	and
